Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
NASDAQ:ATRA
Price:
0.6036 USD
Market Closed
Updated:
May 17, 2024
Atara Biotherapeutics Inc
Total Current Assets
|
Atara Biotherapeutics Inc
Total Current Assets Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Total Current Assets
$106.4m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Current Assets
$33B
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
6%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Current Assets
$12.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
0%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Current Assets
$28B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Current Assets
$14.1B
|
CAGR 3-Years
20%
|
CAGR 5-Years
30%
|
CAGR 10-Years
24%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Current Assets
$18.9B
|
CAGR 3-Years
23%
|
CAGR 5-Years
22%
|
CAGR 10-Years
26%
|
See Also
What is Atara Biotherapeutics Inc's Total Current Assets?
Total Current Assets
106.4m
USD
106.4m
USD
Based on the financial report for Mar 31, 2024, Atara Biotherapeutics Inc's Total Current Assets amounts to 106.4m USD.
What is Atara Biotherapeutics Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
-16%
-16%
Over the last year, the Total Current Assets growth was -53%. The average annual Total Current Assets growth rates for Atara Biotherapeutics Inc have been -39% over the past three years , -16% over the past five years .
You don't have any saved screeners yet
